This is a snippet of the transcript, sign up to read more.
So, the typical German administrative tasks involve collecting a lot of data, like annual journals for employees in the project, timesheets, company information such as R&D spending, annual revenue, and more. This is what people in companies usually don't want to do. Simply collecting data isn't enough in Germany; it must be prepared in a specific way for the tax office to accept it. This is where Innoscripta comes in. I was looking for someone to handle all the administrative work while supporting us in the first stage of getting approval. When I spoke to various companies during the benchmark, most said they would support us and review documents, but couldn't handle everything. Innoscripta, however, offered to manage the tasks we didn't want to do, and at a fair price. Their pricing model isn't different from others, but their USP and the value they add through their IMS system are enormous for our company.
This is a snippet of the transcript, sign up to read more.
Normally, you conduct a kickoff with them, they record it, and you bring your colleague responsible for the project. We spoke to the experts from Innoscripta for one or two hours. They wrote the first approval proposal document in Word, shared it with us, and we corrected it. Initially, it was quite chaotic because they wrote things like, "We have done this and that," and I had to correct them, saying, "We haven't done that. We never said we did that."
This is a snippet of the transcript, sign up to read more.
They try to make the proposal interesting, but you have to be cautious. This is common with these companies; they aim to write a compelling proposal to satisfy the authority. However, at the end of the day, I have to be satisfied, and my boss has to be satisfied. Otherwise, there could be problems if someone reviews the project and finds discrepancies. Therefore, in every part of the project, you have to be careful and control it.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research